|
G |
Ahr |
aryl-hydrocarbon receptor |
multiple interactions |
ISO |
fluvalinate analog promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:25684042 |
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
affects binding |
ISO |
fluvalinate binds to CDK2 protein |
CTD |
PMID:32278787 |
|
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
affects binding |
ISO |
fluvalinate binds to ERBB2 protein |
CTD |
PMID:32278787 |
|
NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
affects binding |
ISO |
fluvalinate binds to FGFR2 protein |
CTD |
PMID:32278787 |
|
NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
affects binding |
ISO |
fluvalinate binds to MMP9 protein |
CTD |
PMID:32278787 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
affects binding |
ISO |
fluvalinate binds to NQO1 protein |
CTD |
PMID:32278787 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
fluvalinate inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO EXP |
fluvalinate binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:21115097 |
|
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
|
|
G |
Ppard |
peroxisome proliferator activator receptor delta |
affects binding |
ISO |
fluvalinate binds to PPARD protein |
CTD |
PMID:32278787 |
|
NCBI chr17:28,451,715...28,520,446
Ensembl chr17:28,451,674...28,520,448
|
|
G |
Rora |
RAR-related orphan receptor alpha |
affects binding |
ISO |
fluvalinate binds to RORA protein |
CTD |
PMID:32278787 |
|
NCBI chr 9:68,560,627...69,295,528
Ensembl chr 9:68,561,068...69,295,528
|
|
G |
Rorc |
RAR-related orphan receptor gamma |
affects binding |
ISO |
fluvalinate binds to RORC protein |
CTD |
PMID:32278787 |
|
NCBI chr 3:94,280,106...94,305,583
Ensembl chr 3:94,280,101...94,305,583
|
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
affects binding |
ISO |
ledipasvir binds to ABCG2 protein |
CTD |
PMID:33954893 |
|
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
G |
Klrc1 |
killer cell lectin-like receptor subfamily C, member 1 |
decreases expression |
ISO |
ledipasvir co-treated with sofosbuvir decreases expression of NCR1 protein in natural killer cells |
RGD |
PMID:31218578 |
RGD:40400920 |
NCBI chr 6:129,642,978...129,659,815
Ensembl chr 6:129,642,978...129,655,936
|
|
G |
Ncr1 |
natural cytotoxicity triggering receptor 1 |
affects expression |
ISO |
ledipasvir co-treated sofosbuvir with affects expression of NCR1 protein in natural killer cells |
RGD |
PMID:31218578 |
RGD:40400920 |
NCBI chr 7:4,340,714...4,348,183
Ensembl chr 7:4,340,723...4,348,163
|
|
|
G |
Abcb11 |
ATP-binding cassette, sub-family B member 11 |
decreases activity multiple interactions |
ISO |
Ritonavir results in decreased activity of ABCB11 protein Ritonavir inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] |
CTD |
PMID:20829430 PMID:22646477 PMID:23956101 PMID:24014644 PMID:28437613 |
|
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
multiple interactions |
ISO |
hyperforin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; hypericin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; kaempferol inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; Quercetin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir] |
CTD |
PMID:15266218 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcb4 |
ATP-binding cassette, sub-family B member 4 |
decreases expression decreases activity |
ISO |
Ritonavir results in decreased expression of ABCB4 Ritonavir results in decreased activity of ABCB4 protein |
CTD |
PMID:26626330 PMID:28437613 |
|
NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
affects expression |
ISO |
Ritonavir affects the expression of ACSS2 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 2:155,359,963...155,404,663
Ensembl chr 2:155,359,868...155,427,644
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
decreases expression multiple interactions |
EXP ISO |
Ritonavir results in decreased expression of ADIPOQ mRNA; Ritonavir results in decreased expression of ADIPOQ protein rosiglitazone inhibits the reaction [Ritonavir results in decreased secretion of ADIPOQ protein] diphenyleneiodonium inhibits the reaction [Ritonavir results in decreased expression of ADIPOQ protein] |
CTD |
PMID:15865214 PMID:17668557 |
|
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
increases phosphorylation |
EXP |
Ritonavir results in increased phosphorylation of AKT1 protein |
CTD |
PMID:36198369 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Ritonavir binds to ALB protein |
CTD |
PMID:15814459 PMID:16336266 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
Ritonavir results in increased expression of BAK1 protein |
CTD |
PMID:19386116 |
|
NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
decreases expression |
ISO |
Ritonavir results in decreased expression of BCL2 protein |
CTD |
PMID:19386116 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
decreases expression |
ISO |
Ritonavir results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:16174765 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
Ritonavir results in decreased expression of BIRC5 mRNA; Ritonavir results in decreased expression of BIRC5 protein |
CTD |
PMID:16174765 PMID:21270666 |
|
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
|
|
G |
Casp1 |
caspase 1 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CASP1 protein |
CTD |
PMID:10551732 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp3 |
caspase 3 |
decreases activity |
ISO |
Ritonavir results in decreased activity of CASP3 protein |
CTD |
PMID:10551732 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression increases secretion decreases expression |
ISO |
diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of CCL2 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased secretion of CCL2 protein] Ritonavir results in decreased expression of CCL2 |
CTD |
PMID:17668557 PMID:20884875 PMID:26626330 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CCL20 |
CTD |
PMID:26626330 |
|
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
decreases expression increases expression |
ISO |
Ritonavir results in decreased expression of CCL3 Ritonavir results in increased expression of CCL3 protein |
CTD |
PMID:17668557 PMID:26626330 |
|
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CCL4 |
CTD |
PMID:26626330 |
|
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CCNA2 mRNA |
CTD |
PMID:19386116 |
|
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CCNB1 mRNA |
CTD |
PMID:19386116 |
|
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CCND1 protein |
CTD |
PMID:16551874 PMID:21270666 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CCND2 mRNA |
CTD |
PMID:16174765 PMID:19386116 |
|
NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
|
|
G |
Ccne2 |
cyclin E2 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CCNE2 mRNA |
CTD |
PMID:19386116 |
|
NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CDK2 mRNA; Ritonavir results in decreased expression of CDK2 protein |
CTD |
PMID:16551874 PMID:19386116 |
|
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
|
|
G |
Cdk3 |
cyclin dependent kinase 3 |
increases expression |
ISO |
Ritonavir results in increased expression of CDK3 mRNA |
CTD |
PMID:19386116 |
|
NCBI chr11:116,106,828...116,111,113
Ensembl chr11:116,106,829...116,111,113
|
|
G |
Cdk4 |
cyclin dependent kinase 4 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CDK4 mRNA; Ritonavir results in decreased expression of CDK4 protein |
CTD |
PMID:16551874 PMID:19386116 |
|
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
|
|
G |
Cdk5 |
cyclin dependent kinase 5 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CDK5 mRNA |
CTD |
PMID:19386116 |
|
NCBI chr 5:24,612,595...24,628,737
Ensembl chr 5:24,623,239...24,628,528
|
|
G |
Cdk6 |
cyclin dependent kinase 6 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CDK6 mRNA; Ritonavir results in decreased expression of CDK6 protein |
CTD |
PMID:16551874 PMID:19386116 |
|
NCBI chr 5:3,391,004...3,581,008
Ensembl chr 5:3,391,485...3,581,008
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO |
manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased expression of CDKN1A protein] Ritonavir results in increased expression of CDKN1A mRNA; Ritonavir results in increased expression of CDKN1A protein |
CTD |
PMID:19386116 PMID:20884875 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
increases expression |
ISO |
Ritonavir results in increased expression of CDKN1B mRNA |
CTD |
PMID:19386116 |
|
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
|
|
G |
Cdkn2b |
cyclin dependent kinase inhibitor 2B |
increases expression |
ISO |
Ritonavir results in increased expression of CDKN2B mRNA |
CTD |
PMID:19386116 |
|
NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions |
EXP |
Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPA protein] |
CTD |
PMID:11101056 |
|
NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
|
|
G |
Ciita |
class II transactivator |
increases expression |
ISO |
Ritonavir results in increased expression of CIITA |
CTD |
PMID:26626330 |
|
NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
|
|
G |
Crot |
carnitine O-octanoyltransferase |
decreases expression |
ISO |
Ritonavir results in decreased expression of CROT mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 5:9,016,033...9,047,926
Ensembl chr 5:9,016,033...9,047,324
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CXCL1 |
CTD |
PMID:26626330 |
|
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CXCL10 |
CTD |
PMID:26626330 |
|
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CXCL12 |
CTD |
PMID:26626330 |
|
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
multiple interactions decreases expression increases secretion |
ISO |
Pravastatin inhibits the reaction [Ritonavir results in increased secretion of CXCL8 protein] Ritonavir results in decreased expression of CXCL8 |
CTD |
PMID:20884875 PMID:26626330 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CXCL2 |
CTD |
PMID:26626330 |
|
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CXCL1 |
CTD |
PMID:26626330 |
|
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cxcl5 |
C-X-C motif chemokine ligand 5 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CXCL6 |
CTD |
PMID:26626330 |
|
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
affects expression |
ISO |
Ritonavir affects the expression of CYB5R3 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr15:83,037,696...83,060,641
Ensembl chr15:83,037,695...83,056,793
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression decreases activity |
ISO |
Ritonavir results in increased expression of CYP1A1 mRNA Ritonavir results in decreased activity of CYP1A1 protein |
CTD |
PMID:11918509 PMID:33814510 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression decreases expression |
ISO |
Ritonavir results in increased expression of CYP1A2 mRNA Ritonavir results in decreased expression of CYP1A2 mRNA |
CTD |
PMID:11918509 PMID:17719200 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
Ritonavir results in decreased activity of CYP1B1 protein |
CTD |
PMID:33814510 |
|
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
|
|
G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
increases activity increases expression |
ISO |
Ritonavir results in increased activity of CYP2B6 protein Ritonavir results in increased expression of CYP2B6 protein |
CTD |
PMID:14977870 PMID:26626330 |
|
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
|
|
G |
Cyp2c29 |
cytochrome P450, family 2, subfamily c, polypeptide 29 |
decreases activity |
ISO |
Ritonavir results in decreased activity of CYP2C8 protein |
CTD |
PMID:15601807 |
|
NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
|
|
G |
Cyp2c38 |
cytochrome P450, family 2, subfamily c, polypeptide 38 |
increases expression |
ISO |
Ritonavir results in increased expression of CYP2C19 mRNA |
CTD |
PMID:11918509 |
|
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
|
|
G |
Cyp2c65 |
cytochrome P450, family 2, subfamily c, polypeptide 65 |
increases activity increases expression |
ISO |
Ritonavir results in increased activity of CYP2C9 protein Ritonavir results in increased expression of CYP2C9 mRNA |
CTD |
PMID:11918509 PMID:19202563 |
|
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
|
|
G |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
affects metabolic processing |
ISO |
CYP2D6 protein affects the metabolism of Ritonavir |
CTD |
PMID:15286053 |
|
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
|
|
G |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
decreases activity |
ISO |
Ritonavir results in decreased activity of CYP3A5 protein |
CTD |
PMID:15523003 |
|
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
affects expression decreases expression |
ISO |
Ritonavir affects the expression of CYP4B1 mRNA Ritonavir results in decreased expression of CYP4B1 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 4:115,481,895...115,504,918
Ensembl chr 4:115,481,922...115,504,920
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
increases expression |
ISO |
Ritonavir results in increased expression of CYP51 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746
|
|
G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:17719200 PMID:26626330 |
|
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
|
|
G |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
decreases expression |
ISO |
Ritonavir results in decreased expression of CYP8B1 Ritonavir results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:17719200 PMID:26626330 |
|
NCBI chr 9:121,743,422...121,745,371
Ensembl chr 9:121,743,422...121,745,371
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
affects expression |
ISO |
Ritonavir affects the expression of DHCR7 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 7:143,376,827...143,402,147
Ensembl chr 7:143,376,882...143,402,147
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
Ritonavir results in decreased expression of E2F1 mRNA; Ritonavir results in decreased expression of E2F1 protein |
CTD |
PMID:19386116 |
|
NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
|
|
G |
E2f2 |
E2F transcription factor 2 |
decreases expression |
ISO |
Ritonavir results in decreased expression of E2F2 mRNA |
CTD |
PMID:19386116 |
|
NCBI chr 4:135,899,585...135,923,368
Ensembl chr 4:135,899,705...135,923,368
|
|
G |
E2f3 |
E2F transcription factor 3 |
decreases expression |
ISO |
Ritonavir results in decreased expression of E2F3 mRNA |
CTD |
PMID:19386116 |
|
NCBI chr13:30,090,558...30,171,172
Ensembl chr13:30,090,558...30,170,046
|
|
G |
Ehhadh |
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
affects expression |
ISO |
Ritonavir affects the expression of EHHADH mRNA |
CTD |
PMID:17719200 |
|
NCBI chr16:21,580,035...21,606,589
Ensembl chr16:21,580,037...21,606,557
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
decreases expression |
ISO |
Ritonavir results in decreased expression of ESR1 protein |
CTD |
PMID:16551874 |
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Fasl |
Fas ligand |
decreases expression |
ISO |
Ritonavir results in decreased expression of FASLG protein |
CTD |
PMID:10551732 |
|
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
|
|
G |
Fasn |
fatty acid synthase |
affects expression |
ISO |
Ritonavir affects the expression of FASN mRNA |
CTD |
PMID:17719200 |
|
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
|
|
G |
Fgf15 |
fibroblast growth factor 15 |
increases expression |
ISO |
Ritonavir results in increased expression of FGF19 mRNA |
CTD |
PMID:26626330 |
|
NCBI chr 7:144,450,269...144,454,690
Ensembl chr 7:144,450,268...144,454,690
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
increases expression |
ISO |
Ritonavir results in increased expression of FOS protein |
CTD |
PMID:15504750 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Glb1 |
galactosidase, beta 1 |
multiple interactions increases activity |
ISO |
Acetylcysteine inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; FTI 277 inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased activity of GLB1 protein] |
CTD |
PMID:20884875 |
|
NCBI chr 9:114,230,146...114,303,447
Ensembl chr 9:114,230,144...114,303,966
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
multiple interactions |
EXP |
Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of GPD1 protein] |
CTD |
PMID:11101056 |
|
NCBI chr15:99,615,468...99,622,895
Ensembl chr15:99,615,396...99,622,886
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Bilirubin inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; HMOX1 protein inhibits the reaction [Ritonavir results in increased expression of ICAM1 protein]; NFE2L2 protein mutant form inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Ritonavir promotes the reaction [Atazanavir Sulfate results in increased expression of HMOX1 mRNA]; Ritonavir promotes the reaction [HMOX1 protein results in increased chemical synthesis of Bilirubin]; Ritonavir promotes the reaction [Lopinavir results in increased expression of HMOX1 mRNA]; Rotenone inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; tricarbonyldichlororuthenium (II) dimer promotes the reaction [Ritonavir results in increased expression of HMOX1 protein] Ritonavir results in increased expression of HMOX1 mRNA; Ritonavir results in increased expression of HMOX1 protein |
CTD |
PMID:15504750 PMID:26968795 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
affects response to substance |
EXP |
HSP90AA1 protein affects the susceptibility to Ritonavir |
CTD |
PMID:16551874 |
|
NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162
|
|
G |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
increases expression |
ISO |
Ritonavir results in increased expression of HSPH1 protein |
CTD |
PMID:26626330 |
|
NCBI chr 5:149,540,308...149,562,594
Ensembl chr 5:149,537,752...149,559,841
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression multiple interactions |
ISO |
Ritonavir results in increased expression of ICAM1 protein HMOX1 protein inhibits the reaction [Ritonavir results in increased expression of ICAM1 protein] |
CTD |
PMID:26968795 |
|
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Ritonavir inhibits the reaction [IFNG protein results in increased secretion of TNF protein] |
CTD |
PMID:10551732 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression increases secretion |
ISO EXP |
diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of IL6 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased secretion of IL6 protein]; Ritonavir inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] rosiglitazone inhibits the reaction [Ritonavir results in increased expression of IL6 mRNA] Ritonavir results in increased expression of IL6 mRNA; Ritonavir results in increased expression of IL6 protein |
CTD |
PMID:15388451 PMID:15865214 PMID:17668557 PMID:20884875 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Il7 |
interleukin 7 |
decreases expression |
ISO |
Ritonavir results in decreased expression of IL7 |
CTD |
PMID:26626330 |
|
NCBI chr 3:7,637,088...7,678,820
Ensembl chr 3:7,635,054...7,678,820
|
|
G |
Ins1 |
insulin I |
multiple interactions |
EXP |
Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPA protein]; Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein]; Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of GPD1 protein]; Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SREBF1 protein] |
CTD |
PMID:11101056 |
|
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
Jun |
jun proto-oncogene |
increases expression |
ISO |
Ritonavir results in increased expression of JUN protein |
CTD |
PMID:15504750 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Lep |
leptin |
multiple interactions decreases expression |
ISO |
diphenyleneiodonium inhibits the reaction [Ritonavir results in decreased expression of LEP protein] |
CTD |
PMID:17668557 |
|
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
|
|
G |
Lif |
leukemia inhibitory factor |
decreases expression |
ISO |
Ritonavir results in decreased expression of LIF |
CTD |
PMID:26626330 |
|
NCBI chr11:4,207,587...4,222,514
Ensembl chr11:4,207,557...4,222,514
|
|
G |
Lmna |
lamin A |
increases expression increases farnesylation |
ISO |
Ritonavir results in increased expression of LMNA protein Ritonavir results in increased farnesylation of LMNA protein alternative form |
CTD |
PMID:18230615 PMID:20884875 |
|
NCBI chr 3:88,388,455...88,413,842
Ensembl chr 3:88,387,454...88,417,263
|
|
G |
Lpl |
lipoprotein lipase |
affects expression |
EXP |
Ritonavir affects the expression of LPL mRNA |
CTD |
PMID:11741158 |
|
NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
|
|
G |
Myc |
myelocytomatosis oncogene |
decreases expression |
ISO |
Ritonavir results in decreased expression of MYC mRNA |
CTD |
PMID:16174765 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
increases expression multiple interactions |
ISO |
Ritonavir results in increased expression of NFE2L2 protein NFE2L2 protein mutant form inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA] |
CTD |
PMID:26968795 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
decreases activity |
ISO |
Ritonavir results in decreased activity of NFKB1 protein |
CTD |
PMID:16174765 |
|
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
decreases phosphorylation |
ISO |
Ritonavir results in decreased phosphorylation of NFKBIA protein |
CTD |
PMID:16174765 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nlrc5 |
NLR family, CARD domain containing 5 |
decreases expression |
ISO |
Ritonavir results in decreased expression of NLRC5 |
CTD |
PMID:26626330 |
|
NCBI chr 8:95,160,963...95,253,900
Ensembl chr 8:95,160,984...95,253,900
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
multiple interactions decreases expression |
ISO |
Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 mRNA] |
CTD |
PMID:22037733 |
|
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Notch4 |
notch 4 |
decreases expression multiple interactions |
ISO |
Ritonavir results in decreased expression of NOTCH4 protein [Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of NOTCH4 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein] |
CTD |
PMID:20722969 |
|
NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
increases expression |
ISO |
Ritonavir increases expression of NR1H3 mRNA in macrophages |
RGD |
PMID:18849545 |
RGD:401842387 |
NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
increases expression |
ISO |
Ritonavir results in increased expression of NR1H4 mRNA |
CTD |
PMID:26626330 |
|
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases activity |
ISO |
Ritonavir binds to and results in increased activity of NR1I2 protein Ritonavir results in increased activity of NR1I2 protein |
CTD |
PMID:14977870 PMID:15849716 PMID:27732639 |
|
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
increases cleavage |
ISO |
Ritonavir results in increased cleavage of PARP1 protein |
CTD |
PMID:19386116 PMID:21270666 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Pon1 |
paraoxonase 1 |
decreases activity |
ISO |
Ritonavir results in decreased activity of PON1 protein |
CTD |
PMID:27378623 |
|
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
multiple interactions increases expression |
EXP ISO |
Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein] Ritonavir results in increased expression of PPARG mRNA |
CTD |
PMID:11101056 PMID:17879945 |
|
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions increases activity increases expression |
EXP |
Ritonavir binds to and affects the localization of PRKCA protein Ritonavir results in increased activity of PRKCA protein Ritonavir results in increased expression of PRKCA protein |
CTD |
PMID:22020176 |
|
NCBI chr11:107,824,213...108,237,360
Ensembl chr11:107,824,213...108,234,754
|
|
G |
Psma1 |
proteasome subunit alpha 1 |
affects expression |
ISO |
Ritonavir affects the expression of PSMA1 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 7:113,863,785...113,875,351
Ensembl chr 7:113,863,841...113,875,353
|
|
G |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
affects expression |
ISO |
Ritonavir affects the expression of PSMB3 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr11:97,594,260...97,604,326
Ensembl chr11:97,594,225...97,604,326
|
|
G |
Psmb5 |
proteasome (prosome, macropain) subunit, beta type 5 |
increases expression |
ISO |
Ritonavir results in increased expression of PSMB5 mRNA |
CTD |
PMID:20213465 |
|
NCBI chr14:54,851,577...54,855,452
Ensembl chr14:54,851,576...54,855,479
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation increases expression |
ISO |
Ritonavir results in decreased phosphorylation of RB1 protein Ritonavir results in increased expression of RB1 mRNA |
CTD |
PMID:16551874 PMID:19386116 PMID:21270666 |
|
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
|
|
G |
Rbl1 |
RB transcriptional corepressor like 1 |
increases expression |
ISO |
Ritonavir results in increased expression of RBL1 mRNA |
CTD |
PMID:19386116 |
|
NCBI chr 2:156,987,813...157,046,454
Ensembl chr 2:156,987,813...157,046,454
|
|
G |
Rbl2 |
RB transcriptional corepressor like 2 |
decreases expression |
ISO |
Ritonavir results in decreased expression of RBL2 mRNA |
CTD |
PMID:19386116 |
|
NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472
|
|
G |
Rel |
reticuloendotheliosis oncogene |
decreases activity |
ISO |
Ritonavir results in decreased activity of REL protein |
CTD |
PMID:16174765 |
|
NCBI chr11:23,686,847...23,720,969
Ensembl chr11:23,686,847...23,720,970
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
decreases activity |
ISO |
Ritonavir results in decreased activity of RELA protein |
CTD |
PMID:16174765 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
multiple interactions increases expression |
ISO |
Estradiol inhibits the reaction [Ritonavir results in increased expression of SCARB1 protein] Ritonavir results in increased expression of SCARB1 mRNA |
CTD |
PMID:17879945 |
|
NCBI chr 5:125,354,151...125,418,082
Ensembl chr 5:125,354,151...125,418,158
|
|
G |
Scp2 |
sterol carrier protein 2, liver |
decreases expression |
ISO |
Ritonavir results in decreased expression of SCP2 |
CTD |
PMID:26626330 |
|
NCBI chr 4:107,901,027...108,002,168
Ensembl chr 4:107,901,036...108,002,195
|
|
G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
decreases expression |
ISO |
Ritonavir results in decreased expression of SLC10A1 |
CTD |
PMID:26626330 |
|
NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
|
|
G |
Slc51a |
solute carrier family 51, alpha subunit |
decreases expression |
ISO |
Ritonavir results in decreased expression of SLC51A |
CTD |
PMID:26626330 |
|
NCBI chr16:32,294,396...32,306,697
Ensembl chr16:32,293,322...32,306,697
|
|
G |
Slco4c1 |
solute carrier organic anion transporter family, member 4C1 |
multiple interactions |
ISO |
Ritonavir inhibits the reaction [SLCO4C1 protein affects the transport of traumatic acid] |
CTD |
PMID:39041788 |
|
NCBI chr 1:96,744,918...96,800,027
Ensembl chr 1:96,743,995...96,799,896
|
|
G |
Src |
Rous sarcoma oncogene |
decreases phosphorylation |
ISO |
Ritonavir results in decreased phosphorylation of SRC protein |
CTD |
PMID:21270666 |
|
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
EXP |
Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SREBF1 protein] |
CTD |
PMID:11101056 |
|
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases phosphorylation |
ISO |
Ritonavir results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:21270666 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Tjp1 |
tight junction protein 1 |
decreases expression multiple interactions |
ISO |
Ritonavir results in decreased expression of TJP1 protein [Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of TJP1 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein] |
CTD |
PMID:20722969 |
|
NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
|
|
G |
Tnf |
tumor necrosis factor |
decreases secretion multiple interactions increases expression |
ISO EXP |
Ritonavir results in decreased secretion of TNF protein rosiglitazone inhibits the reaction [Ritonavir results in increased expression of TNF mRNA] Ritonavir inhibits the reaction [IFNG protein results in increased secretion of TNF protein]; Ritonavir inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Ritonavir results in increased expression of TNF mRNA; Ritonavir results in increased expression of TNF protein |
CTD |
PMID:10551732 PMID:15388451 PMID:15865214 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions increases expression |
ISO |
FTI 277 inhibits the reaction [Ritonavir results in increased expression of TP53 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased expression of TP53 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased expression of TP53 protein] |
CTD |
PMID:19386116 PMID:20884875 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
affects expression |
ISO |
Ritonavir affects the expression of UGT1A1 mRNA |
CTD |
PMID:15849716 |
|
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
|
|
G |
Zmpste24 |
zinc metallopeptidase, STE24 |
decreases activity |
ISO |
Ritonavir results in decreased activity of ZMPSTE24 protein |
CTD |
PMID:18230615 |
|
NCBI chr 4:120,916,434...120,955,452
Ensembl chr 4:120,916,434...120,955,438
|
|
|
G |
App |
amyloid beta precursor protein |
increases abundance multiple interactions |
ISO EXP |
APP protein mutant form results in increased abundance of Valine [APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Valine; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Valine] PF-06840003 inhibits the reaction [APP protein mutant form results in increased abundance of Valine] |
CTD |
PMID:39172838 |
|
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Valine; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Valine] |
CTD |
PMID:22689575 |
|
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
|
|
G |
Mapt |
microtubule-associated protein tau |
increases abundance multiple interactions |
ISO |
MAPT protein mutant form results in increased abundance of Valine PF-06840003 inhibits the reaction [MAPT protein mutant form results in increased abundance of Valine] |
CTD |
PMID:39172838 |
|
NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916
|
|
G |
Psen1 |
presenilin 1 |
multiple interactions |
EXP |
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Valine; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Valine] |
CTD |
PMID:39172838 |
|
NCBI chr12:83,734,926...83,781,869
Ensembl chr12:83,734,926...83,781,973
|
|